MiMedx Group Inc (NASDAQ: MDXG) stock suffered a major decline of -10.3% on 8/1/24. The shares closed at $6.68. Moreover, exceptionally high trading volume at 278% of normal accompanied the decline. The stock has been weak relative to the market over the last nine months and has declined -9.5% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be above the cost of capital, MDXG is expected to continue to be a major Value Builder.
MiMedx Group has a current Value Trend Rating of F (Lowest Rating). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. MiMedx Group has a slightly negative Power Rating of 38 and a poor Appreciation Score of 21, producing the Lowest Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment